Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 228 | 678 | 98 | 317 | 1,225 |
| TOTAL | $279 | $740 | $187 | $332 | $1,315 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 2,600 | 0 | 114 |
| TOTAL | $N/A | $N/A | $2,600 | $N/A | $114 |
| Total Assets | $279 | $740 | $2,787 | $332 | $1,429 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,289 | 16,378 | 3,171 | 2,426 | 17,165 |
| Accrued Expenses | 3,141 | 2,668 | 2,148 | 1,649 | 1,164 |
| Other current liabilities | 410 | 522 | 503 | 476 | 479 |
| TOTAL | $21,850 | $19,578 | $5,841 | $4,561 | $18,818 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 16,505 | 12,076 | 650 |
| TOTAL | $N/A | $N/A | $16,505 | $12,076 | $650 |
| Total Liabilities | $21,850 | $19,578 | $22,346 | $16,637 | $19,468 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 352 | 343 | 295 | 294 | 294 |
| Common Shares | 169 | 160 | 141 | 141 | 141 |
| Retained earnings | -75,351 | -71,232 | -67,659 | -63,812 | -59,932 |
| TOTAL | $-21,572 | $-18,838 | $-19,559 | $-16,305 | $-18,038 |
| Total Liabilities And Equity | $279 | $740 | $2,787 | $332 | $1,429 |